FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
Tag:
FDA approval
-
-
Oral Wegovy Approved: A New Option for Weight Loss A new oral version of the weight loss drug Wegovy has been approved by the Food and Drug Administration (FDA), offering …
-
Mitapivat Approved: A New Treatment for Thalassemia Anemia Table of Contents Mitapivat Approved: A New Treatment for Thalassemia Anemia What is thalassemia? Symptoms of Thalassemia How Does Mitapivat Work? Clinical …
-
here’s a summary of the provided text: Key Takeaways: FDA Approval: The FDA has approved pegcetacoplan (Empaveli), developed by Apellis Pharmaceuticals, as the first treatment for C3 glomerulopathy (C3G) and …
-
A New Approach to Dry Eye Relief: Acotremon Ophthalmic Solution Table of Contents A New Approach to Dry Eye Relief: Acotremon Ophthalmic Solution Understanding the Scope of Dry Eye Disease …